Ozempic at 65: Your Muscles Are Paying the Price
There is a particular kind of confidence that comes with a number on a scale dropping steadily, week after week.
Ozempic at 65: Your Muscles Are Paying the Price
There is a particular kind of confidence that comes with a number on a scale dropping steadily, week after week. I've watched it in friends, in people at the café, in the quietly triumphant way someone orders differently. The GLP-1 drugs — semaglutide, tirzepatide, the whole elegant pharmacological family — have delivered something genuinely remarkable: weight loss that actually works, cardiovascular protection, and now emerging evidence suggesting reduced stroke risk and, intriguingly, lower rates of violent impulsivity. The science is real. The results are real.
But there is a conversation happening underneath those results that doesn't make it onto the Instagram testimonials, and it matters most if you are over sixty-five.
When the body loses weight rapidly — and these medications can produce significant loss in relatively short periods — it doesn't discriminate neatly between fat tissue and muscle tissue. In younger adults, the body tends to preserve more muscle mass, particularly with adequate protein intake and resistance exercise. In older adults, the calculus shifts. A report examining GLP-1 use in people over sixty-five found elevated risks of muscle loss, malnutrition, and dehydration — the cluster of conditions clinicians group under the word *frailty*. That word sounds gentle. It isn't. Muscle loss in older adults is a genuine clinical risk: it affects balance, bone density, recovery from illness, and independence.
This isn't an argument against GLP-1 medications. The cardiovascular evidence alone is compelling enough that dismissing them would be foolish. The point is narrower and more specific: the drug does not know how old you are. Your prescribing doctor does, and should.
What the research suggests is that GLP-1 treatment in older adults requires active counterweight — and that counterweight is protein and resistance training. Not aspirationally, but clinically seriously. Studies consistently show that older adults on GLP-1 medications who prioritise protein intake of around 1.2 to 1.6 grams per kilogram of body weight, and who incorporate two to three sessions of resistance exercise per week, retain significantly more lean muscle mass than those who don't. The medication suppresses appetite; that suppressed appetite can quietly suppress the protein your muscles are waiting for.
I think about the stones in Valletta sometimes — how they hold their shape across centuries precisely because they were built with the right material at the foundation. The body works similarly. Weight loss built on muscle loss is weight loss on borrowed ground.
One thing to do: If you or someone you love is over sixty-five and using a GLP-1 medication, ask their doctor specifically about muscle mass monitoring and protein targets — not just weight and blood sugar. The question itself changes the conversation.
